Condition: Obesity & Overweight · Sponsor: Université Catholique de Louvain
As with other nutritional strategies, the clinical response to bariatric surgery can be highly variable, with weight regain being a frequent occurrence. Recent evidence on anti-obesity medication indicate similar inter-individual variability in clinical response. Among multiples factors, co-occurrence of eating disorders such as binge eating disorder has been implicated in insufficient clinical response. Improving our ability to predict how patients will respond to obesity treatment is necessary in order to tailor the care pathways we offer. The mechanisms involved in disturbances of eating behaviour before and after surgery remain largely unknown. This study aims to identify the predictive factors of weight loss after pharmacological or surgical treatment, as well as the cognitive and biological mechanisms that mediate this effect.
This description comes directly from the study's public registry record.
Pr Amandine Everard, Professor · + 32 (0)2 436 22 10 · amandine.everard@uclouvain.be
Yannick Deswysen, Doctor · + 32 2 764 22 13 · yannick.deswysen@saintluc.uclouvain.be
Always discuss trial participation with your own doctor first.
| Cliniques Universitaires Saint-Luc | Brussels, Brussels Capital, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07402031